BlackRock’s Mereo BioPharma MREO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.23M | Buy |
455,365
+181,004
| +66% | +$491K | ﹤0.01% | 4120 |
|
|
2025
Q1 | $617K | Buy |
274,361
+1,342
| +0.5% | +$3.02K | ﹤0.01% | 4292 |
|
|
2024
Q4 | $956K | Buy |
273,019
+258,698
| +1,806% | +$905K | ﹤0.01% | 4180 |
|
|
2024
Q3 | $58.9K | Sell |
14,321
-2,471
| -15% | -$10.2K | ﹤0.01% | 4730 |
|
|
2024
Q2 | $60.5K | Sell |
16,792
-16,051
| -49% | -$57.8K | ﹤0.01% | 4769 |
|
|
2024
Q1 | $108K | Buy |
32,843
+26,911
| +454% | +$88.8K | ﹤0.01% | 4648 |
|
|
2023
Q4 | $13.7K | Buy |
+5,932
| New | +$13.7K | ﹤0.01% | 5048 |
|
|
2022
Q4 | – | Sell |
-657,182
| Closed | -$565K | – | 5714 |
|
|
2022
Q3 | $565K | Sell |
657,182
-18,850
| -3% | -$16.2K | ﹤0.01% | 4599 |
|
|
2022
Q2 | $757K | Sell |
676,032
-73,569
| -10% | -$82.4K | ﹤0.01% | 4556 |
|
|
2022
Q1 | $840K | Buy |
749,601
+278,729
| +59% | +$312K | ﹤0.01% | 4633 |
|
|
2021
Q4 | $753K | Buy |
470,872
+456,572
| +3,193% | +$730K | ﹤0.01% | 4681 |
|
|
2021
Q3 | $35K | Buy |
14,300
+1,341
| +10% | +$3.28K | ﹤0.01% | 5268 |
|
|
2021
Q2 | $41K | Buy |
12,959
+12,794
| +7,754% | +$40.5K | ﹤0.01% | 5142 |
|
|
2021
Q1 | $1K | Buy |
+165
| New | +$1K | ﹤0.01% | 5185 |
|